The FDA and DePuy have issued a class-1 recall, the highest alert, of DePuy’s femur and tibia implant called the LPS Lower Extremity Dovetail Intercalary Component. This is because this device has the potential to fracture when the patient walks normally or conducts normal activities – like ascending stairs, or rising from a chair. People weighing over 200 pounds or with high activity levels are at higher risk of fractures.
Thornton Law Firm Blog
Generic Drugs Manufacturers Further Protected From Lawsuits
Posted by Thornton Law Firm LLP on Jul 29, 2013 7:23:00 AM In a 5-4 decision, last month, the Supreme Court of the United States ruled that generic drug manufacturers are shielded from lawsuits arising from adverse side effects caused by their drugs. From now on, only...
Thornton Law Firm Attorneys Named New England’s Best Lawyers
Thornton Law Firm is pleased to announce the selection of two of the firm’s attorneys as “New England’s Best Lawyers” for 2013 by New England’s Best Lawyers ®.
The Hidden Perils Of Summer: Spray-On Sunscreen
When you’re about to go out in the sun, you should definitely wear sunscreen. But did you know that many sunscreen sprays contain flammable ingredients, most commonly alcohol? If you apply sunscreen sprays and then come close to a source of flame, like the barbecue grill, lighting a fire or even coming too close to a lit candle, you may risk the sunscreen catching fire and causing you a serious burn. A recent FDA Consumer Update says that it has received reports of five incidents where people wearing spray sunscreen near open flame suffered significant burns; significant enough to require medical treatment.
Independence Day
Posted by Michael Lesser on Jul 4, 2013 10:11:00 AM We hold these truths to be self-evident, that all men are created equal, that they are endowed by their Creator with certain unalienable Rights, that among these are Life, Liberty and the pursuit of Happiness. -...
CR Bard Intentionally Used Plastic Unfit For Humans In Avaulta Mesh
Posted by Marilyn McGoldrick on Jul 1, 2013 4:06:00 PM Newly-unsealed confidential records show that C.R. Bard, Inc., knowingly ignored a part supplier’s direct warning that the plastic Bard was supplied with was unsuitable for human implantation. The revelation about...
Many Birth Defects Caused By Toxic Chemical Exposures During Pregnancy
Posted by David C. Strouss on Jun 28, 2013 2:36:00 PM July is National Cleft and Craniofacial Awareness and Prevention Month (NCCAPM). NCCAPM and its partner organizations maintain a variety of programs throughout the year offering services for patients and families,...
New Pretrial Orders Issued In Transvaginal Mesh MDL
By Marilyn T. McGoldrick, Esq. Posted on June 19, 2013 Last week the West Virginia court overseeing the vaginal mesh litigation involving Johnson & Johnson's Ethicon unit issued a pair of new pre-trial orders. The first rescheduled the presentation of possible...
Stryker Hip Implant Cases Consolidated In Minnesota
By Marilyn T. McGoldrick, Esq. Posted on June 17, 2013 On June 12, 2013, the U.S. Judicial Panel on Multidistrict Litigation (JPMDL) transferred more than 39 Stryker Rejuvenate and ABGII defective hip cases to the U.S. District Court of Minnesota. The MDL was approved...
Statin Use Linked To Type-2 Diabetes Risk
Posted by Marilyn McGoldrick on Jun 3, 2013 3:53:00 PM Since their use became common in the 1990s, “statins” have been prescribed for millions of patients, earning drug companies hundreds of billions in revenue. Now, however, after almost three decades of heavy usage,...
Stryker Hires Broadspire To Evaluate Claims Re Defective Hip Implants
As part of a recall affecting thousands of its metal-on-metal hips, Stryker has hired a third-party claims administrator, Broadspire Services, Inc., to evaluate claims for reimbursement of costs associated with its recalled hips. Stryker is offering to reimburse patients for testing, treatment, revision surgery and other costs associated to the recall.
Massachusetts Dialysis Co. Products Recalled For Serious Health Risks
The FDA has issued a Class I recall of dialysis concentrates GranuFlo andNaturaLyte because the products could put patients at risk for heart attacks and other serious cardiovascular problems. These products would have been administered to dialysis patients being seen in facilities run by or supplied by Fresenius Medical Care North America, the manufacturer of GranuFlo & NaturaLyte.